- call +1-201-465-4211
- email sales@mrinsights.biz
Novartis AG (Switzerland), Pfizer Inc. (U.S), Sanofi (France), Merck & Co., Inc. (U.S), Astellas (Japan), Bayer AG (Germany)
Scope of the Report:
Increasing prevalence of HIV in Asia Pacific region is the key factor for the market growth. Rising awareness about the antifungal treatment and availability of new treatment methods drive the market in Asia Pacific region. In Asia Pacific, the market shows growth opportunities in China and India. China is expected to be the fastest growing market.
The global Antifungal market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antifungal.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Antifungal market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Antifungal market by product type and applications/end industries.
Market Segment by Companies, this report covers
Novartis (Switzerland)
Pfizer (U.S)
Sanofi (France)
Merck (U.S)
Astellas (Japan)
Bayer (Germany)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral Administration
External Use
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Antifungal Market Overview
1.1 Product Overview and Scope of Antifungal
1.2 Classification of Antifungal by Types
1.2.1 Global Antifungal Revenue Comparison by Types (2017-2023)
1.2.2 Global Antifungal Revenue Market Share by Types in 2017
1.2.3 Oral Administration
1.2.4 External Use
1.3 Global Antifungal Market by Application
1.3.1 Global Antifungal Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Sales
1.4 Global Antifungal Market by Regions
1.4.1 Global Antifungal Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Antifungal Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Antifungal Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antifungal Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Antifungal Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antifungal Status and Prospect (2013-2023)
1.5 Global Market Size of Antifungal (2013-2023)
2 Manufacturers Profiles
2.1 Novartis (Switzerland)
2.1.1 Business Overview
2.1.2 Antifungal Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis (Switzerland) Antifungal Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer (U.S)
2.2.1 Business Overview
2.2.2 Antifungal Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer (U.S) Antifungal Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sanofi (France)
2.3.1 Business Overview
2.3.2 Antifungal Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi (France) Antifungal Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck (U.S)
2.4.1 Business Overview
2.4.2 Antifungal Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck (U.S) Antifungal Revenue, Gross Margin and Market Share (2016-2017)
2.5 Astellas (Japan)
2.5.1 Business Overview
2.5.2 Antifungal Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Astellas (Japan) Antifungal Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer (Germany)
2.6.1 Business Overview
2.6.2 Antifungal Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer (Germany) Antifungal Revenue, Gross Margin and Market Share (2016-2017)
3 Global Antifungal Market Competition, by Players
3.1 Global Antifungal Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Antifungal Players Market Share
3.2.2 Top 10 Antifungal Players Market Share
3.3 Market Competition Trend
4 Global Antifungal Market Size by Regions
4.1 Global Antifungal Revenue and Market Share by Regions
4.2 North America Antifungal Revenue and Growth Rate (2013-2018)
4.3 Europe Antifungal Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Antifungal Revenue and Growth Rate (2013-2018)
4.5 South America Antifungal Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Antifungal Revenue and Growth Rate (2013-2018)
5 North America Antifungal Revenue by Countries
5.1 North America Antifungal Revenue by Countries (2013-2018)
5.2 USA Antifungal Revenue and Growth Rate (2013-2018)
5.3 Canada Antifungal Revenue and Growth Rate (2013-2018)
5.4 Mexico Antifungal Revenue and Growth Rate (2013-2018)
6 Europe Antifungal Revenue by Countries
6.1 Europe Antifungal Revenue by Countries (2013-2018)
6.2 Germany Antifungal Revenue and Growth Rate (2013-2018)
6.3 UK Antifungal Revenue and Growth Rate (2013-2018)
6.4 France Antifungal Revenue and Growth Rate (2013-2018)
6.5 Russia Antifungal Revenue and Growth Rate (2013-2018)
6.6 Italy Antifungal Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Antifungal Revenue by Countries
7.1 Asia-Pacific Antifungal Revenue by Countries (2013-2018)
7.2 China Antifungal Revenue and Growth Rate (2013-2018)
7.3 Japan Antifungal Revenue and Growth Rate (2013-2018)
7.4 Korea Antifungal Revenue and Growth Rate (2013-2018)
7.5 India Antifungal Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Antifungal Revenue and Growth Rate (2013-2018)
8 South America Antifungal Revenue by Countries
8.1 South America Antifungal Revenue by Countries (2013-2018)
8.2 Brazil Antifungal Revenue and Growth Rate (2013-2018)
8.3 Argentina Antifungal Revenue and Growth Rate (2013-2018)
8.4 Colombia Antifungal Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Antifungal by Countries
9.1 Middle East and Africa Antifungal Revenue by Countries (2013-2018)
9.2 Saudi Arabia Antifungal Revenue and Growth Rate (2013-2018)
9.3 UAE Antifungal Revenue and Growth Rate (2013-2018)
9.4 Egypt Antifungal Revenue and Growth Rate (2013-2018)
9.5 Nigeria Antifungal Revenue and Growth Rate (2013-2018)
9.6 South Africa Antifungal Revenue and Growth Rate (2013-2018)
10 Global Antifungal Market Segment by Type
10.1 Global Antifungal Revenue and Market Share by Type (2013-2018)
10.2 Global Antifungal Market Forecast by Type (2018-2023)
10.3 Oral Administration Revenue Growth Rate (2013-2023)
10.4 External Use Revenue Growth Rate (2013-2023)
11 Global Antifungal Market Segment by Application
11.1 Global Antifungal Revenue Market Share by Application (2013-2018)
11.2 Antifungal Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Drug Stores Revenue Growth (2013-2018)
11.6 Online Sales Revenue Growth (2013-2018)
12 Global Antifungal Market Size Forecast (2018-2023)
12.1 Global Antifungal Market Size Forecast (2018-2023)
12.2 Global Antifungal Market Forecast by Regions (2018-2023)
12.3 North America Antifungal Revenue Market Forecast (2018-2023)
12.4 Europe Antifungal Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Antifungal Revenue Market Forecast (2018-2023)
12.6 South America Antifungal Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Antifungal Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Antifungal Picture
Table Product Specifications of Antifungal
Table Global Antifungal and Revenue (Million USD) Market Split by Product Type
Figure Glob
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
